Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
DRD1 Biologics Sequence Review Report 2026: D(1A) dopamine receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of DRD1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CNR2 Biologics Sequence Review Report 2026: Cannabinoid receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CNR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CMKLR2 Biologics Sequence Review Report 2026: Chemerin-like receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CMKLR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNB4 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit beta-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNB1 Biologics Sequence Review Report 2026: Acetylcholine receptor subunit beta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNG Biologics Sequence Review Report 2026: Acetylcholine receptor subunit gamma Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNG protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNB2 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit beta-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CASR Biologics Sequence Review Report 2026: Extracellular calcium-sensing receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CASR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA4 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA7 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-7 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CHRNA5 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IGF1R Biologics Sequence Review Report 2026: Insulin-like growth factor 1 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IGF1R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
13
14
15
16
17
>>
1670
>